Literature DB >> 6874722

Epiphysial growth after free fibular transfer with and without microvascular anastomosis. Experimental study in the dog.

K Brown, P Marie, T Lyszakowski, R Daniel, R Cruess.   

Abstract

The proximal fibular epiphysis was transferred in young puppies using microvascular techniques. The study demonstrated, as have previous investigators, that free epiphysial transfer without vascular anastomosis results in death of the chondrocytes of the growth plate. Histologically, the chondrocytes do not take up labelled proline, indicating diminished metabolic activity; do not take up radioactive thymidine, indicating that they are not dividing; and there is eventual disruption of the normal histological picture. In contrast, where the microvascular anastomoses re-established the blood supply to the growth plate, the epiphyses demonstrated normal histological appearance, uptake of radioactive proline and thymidine and continued to grow but at a slightly diminished rate. It is concluded that continued growth can occur after free vascularised epiphysial transfer in the dog.

Entities:  

Mesh:

Year:  1983        PMID: 6874722

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

1.  Case report: histologic study of a human epiphyseal transplant at 3 years after implantation.

Authors:  J Sales de Gauzy; F Accadbled; A Gomez Brouchet; A Abid
Journal:  Clin Orthop Relat Res       Date:  2009-02-11       Impact factor: 4.176

Review 2.  Changing paradigms in the treatment of radial club hand: microvascular joint transfer for correction of radial deviation and preservation of long-term growth.

Authors:  Johanna P de Jong; Steven L Moran; Simo K Vilkki
Journal:  Clin Orthop Surg       Date:  2012-02-20

3.  Reversed vascularized second metatarsal flap for reconstruction of Manske type IIIB and IV thumb hypoplasia with reduced donor site morbidity.

Authors:  De-Di Tong; Le-Hao Wu; Peng-Cheng Li; Yan-Bo Rong; Bo Liu; WPAndrew Lee; Qi-Pei Wei; Lu Liu; He-Jia Miao; Shan-Lin Chen
Journal:  Chin Med J (Engl)       Date:  2019-11-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.